Published: 21 December 2019
Author(s): Rubén Viejo-Moreno, Alberto Cabrejas-Aparicio, Noemí Arriero-Fernández, Manuel Quintana-Díaz, Enrique Galván-Roncero, María de las Nieves Gálvez-Marco, Cristina Carriedo-Scher, Javier Balaguer-Recena, Carlos Marian-Crespo

Ischemic heart disease (IHD) continues to be a major public health problem worldwide [1]. It generates a huge social impact in terms of disability; potential years of life lost, and constitutes the main cause of mortality in the world [2–4]. Despite the advances in medical health care, the future does not seem too bright [5].

Newsletters

Stay informed on our latest news!